Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Günter Heimann

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Statistics in Medicine|March 11, 2003
Non-parametric estimators of a monotonic dose-response curve and bootstrap confidence intervalsMaria Dilleen, Günter Heimann, Ian Hirsch
Journal of Pharmacokinetics and Pharmacodynamics|January 12, 2026
Concentration response analyses for QT data with several active compoundsGünter Heimann, Giulia Lestini, Jochen Zisowsky
Statistics in Medicine|September 10, 2025
Using Confidence Distributions in Final and Interim Analyses for Single-Arm Studies or Platform Trials Consisting of Single-Arm StudiesGünter Heimann, Peter Jacko, Tom Parke
CPT: Pharmacometrics & Systems Pharmacology|May 1, 2021
Exposure-response modeling for extrapolation from adult to pediatric patients who differ with respect to prognostic factors: Application to everolimusThomas Dumortier, Günter Heimann, Martin Fink
Statistical Methods in Medical Research|March 25, 2026
Randomization and allocation procedures for master protocol trials of single-arm studiesPeter Jacko, Günter Heimann, Tom Parke
Journal of Pharmacokinetics and Pharmacodynamics|November 15, 2025
A note on phase I interleaved versus parallel group ascending dose designs for concentration-QTc analysesGünter Heimann, Thomas Dumortier, Karin Meiser
Statistics in Medicine|April 16, 2015
Exact and asymptotic inference in clinical trials with small event rates under inverse samplingGünter Heimann, Mark Von Tress, Mauro Gasparini
Statistics in Medicine|January 12, 2018
A nonparametric method to detect increased frequencies of adverse drug reactions over timeGünter Heimann, Rossella Belleli, Jouni Kerman, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 1, 2019
Cardiac risk assessment based on early Phase I data and PK-QTc analysis is concordant with the outcome of thorough QTc trials: an assessment based on eleven drug candidatesPuneet Gaitonde, Yeamin Huh, Borje Darpo, et al.
Neuro-Oncology Practice|July 15, 2024
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseasesBritt A E Dhaenens, Günter Heimann, Annette Bakker, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Statistics in Medicine|March 11, 2003
Non-parametric estimators of a monotonic dose-response curve and bootstrap confidence intervalsMaria Dilleen, Günter Heimann, Ian Hirsch
Journal of Pharmacokinetics and Pharmacodynamics|January 12, 2026
Concentration response analyses for QT data with several active compoundsGünter Heimann, Giulia Lestini, Jochen Zisowsky
Statistics in Medicine|September 10, 2025
Using Confidence Distributions in Final and Interim Analyses for Single-Arm Studies or Platform Trials Consisting of Single-Arm StudiesGünter Heimann, Peter Jacko, Tom Parke
CPT: Pharmacometrics & Systems Pharmacology|May 1, 2021
Exposure-response modeling for extrapolation from adult to pediatric patients who differ with respect to prognostic factors: Application to everolimusThomas Dumortier, Günter Heimann, Martin Fink
Statistical Methods in Medical Research|March 25, 2026
Randomization and allocation procedures for master protocol trials of single-arm studiesPeter Jacko, Günter Heimann, Tom Parke
Journal of Pharmacokinetics and Pharmacodynamics|November 15, 2025
A note on phase I interleaved versus parallel group ascending dose designs for concentration-QTc analysesGünter Heimann, Thomas Dumortier, Karin Meiser
Statistics in Medicine|April 16, 2015
Exact and asymptotic inference in clinical trials with small event rates under inverse samplingGünter Heimann, Mark Von Tress, Mauro Gasparini
Statistics in Medicine|January 12, 2018
A nonparametric method to detect increased frequencies of adverse drug reactions over timeGünter Heimann, Rossella Belleli, Jouni Kerman, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 1, 2019
Cardiac risk assessment based on early Phase I data and PK-QTc analysis is concordant with the outcome of thorough QTc trials: an assessment based on eleven drug candidatesPuneet Gaitonde, Yeamin Huh, Borje Darpo, et al.
Neuro-Oncology Practice|July 15, 2024
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseasesBritt A E Dhaenens, Günter Heimann, Annette Bakker, et al.
Pageof 1